Fig. 4
From: Mitophagy related gene signature for prognosis and therapeutic evaluation in KIRC
Associations between the MRG-based prognostic model and clinical characteristics in patients with KIRC. (A–F) Kaplan–Meier survival analyses evaluating overall survival (OS) in subgroups stratified by distinct clinical parameters: (A) age (> 65 vs. ≤65 years), (B) sex (female vs. male), (C) tumor grade (low grade: G1–2 vs. high grade: G3–4), (D) metastatic status (non-metastatic: M0 vs. metastatic: M1), (E) clinical stage (early stage: I–II vs. advanced stage: III–IV), and (F) primary tumor classification (T1–2 vs. T3–4).
